ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Research Article

Open Vet J. 2025; 15(11): 5594-5604


Ameliorative potential of quercetin on the possible adverse effects of ketoprofen

Hosny Ibrahim, Esraa Bahgat Shehata Afifi, Azza A.A. Galal, Mohamed M.M. Metwally, Wageh Sobhy Darwish.



Abstract
Download PDF Post

Background:
Ketoprofen (KP) is a nonsteroidal antiinflammatory drug that treats musculoskeletal injuries, osteoarthritis, and acute gouty arthritis. However, its use has been linked to certain detrimental effects on the stomach, liver, and renal function.

Aim:
This study investigated the ameliorative effects of omeprazole and quercetin on the negative effects of KP in rats.

Methods:
The experimental rats were randomly divided into four groups: Group I consisted of negative control rats. Rats were treated with ketoprofen in Group II (50 mg/kg b.wt.), omeprazole in Group III (20 mg/kg b.wt.), and quercetin in Group IV 1 h before ketoprofen (50 mg/kg b.wt.). Gastric juice volume and pH, gastric ulcer, ulcer score and curative ratio, serum biochemical analysis (liver function and kidney function), and evaluation of gastric, hepatic, and renal oxidant/oxidant status were all evaluated.

Results:
The obtained results showed significant ameliorative effects of omeprazole and quercetin against the induced alterations in the liver and kidney function tests compared with those in nontreated rats. In addition, KP caused significant oxidative damage, which was significantly improved upon omeprazole and quercetin administration.

Conclusion:
Therefore, it is highly recommended that either omeprazole and/or quercetin be used during the treatment course by KP to decrease its induced adverse effects.

Key words: Ketoprofen; Omeprazole; Quercetin; Oxidative damage; Rats.







Bibliomed Article Statistics

18
56
37
1
R
E
A
D
S

3

58

19


D
O
W
N
L
O
A
D
S
11120102
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.